Cited by 2,542Cancer Genomics and DiagnosticsCancer Cells and MetastasisMicrofluidic and Bio-sensing Technologies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Allard, W. Jeffrey, Matera, Jeri, Miller, M. Craig, Repollet, Madeline, Connelly, Mark C., Rao, Chandra, Tibbe, Arjan G. J., Uhr, Jonathan W., Terstappen, Leon W. M. M.·2004·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-04-0378

Published version of a preprint

Open this paper in CoChat — free account

Abstract

PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-0378

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Statistics for Experimenters
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263

Show all 30 references

Research works printed but not linked: 8

Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349

Sorted by citations

Items 501–600 of 1,004

Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell
Winer-Jones, J. P., Vahidi, B., Arquilevich, N., Fang, C., Ferguson, S., Harkins, D., Hill, C., Klem, E., Pagano, P. C., Peasley, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086717 · Cited by 78
Genomic High-Resolution Profiling of Single CKpos/CD45neg Flow-Sorting Purified Circulating Tumor Cells from Patients with Metastatic Breast Cancer
Neves, R. P., Raba, K., Schmidt, O., Honisch, E., Meier-Stiegen, F., Behrens, B., Möhlendick, B., Fehm, T. N., Neubauer, H. J., Klein, C. A., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.222331 · Cited by 78
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
Truini, A., Alama, A., Bello, M. G. D., Coco, S., Vanni, I., Rijavec, E., Genova, C., Barletta, G., Biello, F., & Grossi, F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00242 · Cited by 80
Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review
Yang, C., Zou, K., Zheng, L., & Xiong, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3704-8 · Cited by 78
Continual collection and re-separation of circulating tumor cells from blood using multi-stage multi-orifice flow fractionation
Moon, H.-S., Kwon, K., Hyun, K.-A., Sim, T. S., Park, J. C., Lee, J., & Jung, H. (2013) · Biomicrofluidics · doi:10.1063/1.4788914 · Cited by 78
Circulating Tumor Cells: Evolving Evidence and Future Challenges
Dotan, E., Cohen, S. J., Alpaugh, K. R., & Meropol, N. J. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0094 · Cited by 81
Enrichment of circulating tumor cells in tumor-bearing mouse blood by a deterministic lateral displacement microfluidic device
Okano, H., Konishi, T., Suzuki, T., Suzuki, T., Ariyasu, S., Aoki, S., Abe, R., & Hayase, M. (2015) · Biomedical Microdevices · doi:10.1007/s10544-015-9964-7 · Cited by 77
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients
Wallwiener, M., Riethdorf, S., Hartkopf, A. D., Modugno, C., Nees, J., Madhavan, D., Sprick, M. R., Schott, S., Domschke, C., Baccelli, I., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-512 · Cited by 77
Detection of Circulating Tumor Cells
de Wit, S., van Dalum, G., & Terstappen, L. W. M. M. (2014) · Scientifica · doi:10.1155/2014/819362 · Cited by 84
An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
Liu, Y., Hu, B., Li, Z., He, X., Li, Y., & Lu, L. (2016) · Hepatology International · doi:10.1007/s12072-016-9732-7 · Cited by 78
Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
Hanssen, A., Loges, S., Pantel, K., & Wikman, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00207 · Cited by 74
Cancer metastasis through the prism of epithelial‐to‐mesenchymal transition in circulating tumor cells
Micalizzi, D. S., Haber, D. A., & Maheswaran, S. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12081 · Cited by 76
Highly Efficient Capture and Electrochemical Release of Circulating Tumor Cells by Using Aptamers Modified Gold Nanowire Arrays
Zhai, T.-T., Ye, D., Zhang, Q., Wu, Z., & Xia, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11107 · Cited by 77
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Cheng, X., Zhang, L., Chen, Y., & Qing, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0369-5 · Cited by 76
TiO2-based Surface-Enhanced Raman Scattering bio-probe for efficient circulating tumor cell detection on microfilter
Xu, X., Lin, J., Guo, Y., Wu, X., Xu, Y., Zhang, D., Zhang, X., Yujiao, X., Wang, J., Yao, C., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114305 · Cited by 76
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
Eslami‐S, Z., Cortés‐Hernández, L. E., Frédéric Thomas, A., Pantel, K., & Alix‐Panabières, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01819-1 · Cited by 76
Circulating Tumor Microemboli Diagnostics for Patients with Non–Small-Cell Lung Cancer
Carlsson, A., Nair, V. S., Luttgen, M. S., Keu, K. V., Horng, G., Vasanawala, M., Kolatkar, A. R., Jamali, M., Iagaru, A. H., Kuschner, W. G., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000235 · Cited by 76
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters
Bhagwat, N., Dulmage, K., Pletcher, C. H., Wang, L., DeMuth, W., Sen, M., Balli, D., Yee, S. S., Sa, S., Tong, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23217-5 · Cited by 75
Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms
Khan, M. S., Kirkwood, A. A., Tsigani, T., Lowe, H. L., Goldstein, R., Hartley, J. A., Caplin, M. E., & Meyer, T. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1008 · Cited by 75
A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer
Iyer, R. V., Pokuri, V. K., Groman, A. E., Ma, W. W., Malhotra, U., Iancu, D. M., Grande, C., & Bekaii‐Saab, T. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000347 · Cited by 75
Progress and challenges of sequencing and analyzing circulating tumor cells
Zhu, Z., Qiu, S., Shao, K., & Hou, Y. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9418-5 · Cited by 74
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
Nanou, A., Coumans, F. A. W., van Dalum, G., Zeune, L. L., Dolling, D. I., Onstenk, W., Crespo, M., Fontes, M. S., Rescigno, P., Fowler, G., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25019 · Cited by 75
Microfluidics for label-free sorting of rare circulating tumor cells
Zhu, S., Jiang, F., Yu, H., Xiang, N., & Ni, Z. (2020) · The Analyst · doi:10.1039/d0an01148g · Cited by 75
Methods and goals for the use of in vitro and in vivo chemosensitivity testing
Blumenthal, R. D., & Goldenberg, D. M. (2007) · Molecular Biotechnology · doi:10.1007/bf02686104 · Cited by 75
Gold Nanoparticle Based Platforms for Circulating Cancer Marker Detection
Huang, X., O’Connor, R., & Kwizera, E. A. (2017) · Nanotheranostics · doi:10.7150/ntno.18216 · Cited by 76
Blood-based tumor biomarkers in lung cancer for detection and treatment
Mamdani, H. M., Ahmed, S. S., Armstrong, S. A., Mok, T. S. K., & Jalal, S. I. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.09.03 · Cited by 75
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
Nakamura, T., Sueoka‐Aragane, N., Iwanaga, K., Sato, A., Komiya, K., Abe, T., Ureshino, N., Hayashi, S., Hosomi, T., Hirai, M., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822956e8 · Cited by 74
Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival
Danila, D. C., Anand, A., Schultz, N. D., Heller, G., Wan, M., Sung, C. C., Dai, C. S., Khanin, R., Fleisher, M., Lilja, H. G., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.07.006 · Cited by 74
Recent advances in microfluidic cell sorting techniques based on both physical and biochemical principles
Tang, W.-L., Jiang, D., Li, Z.-A., Zhu, L., Shi, J.-P., Yang, J.-Q., & Xiang, N. (2018) · Electrophoresis · doi:10.1002/elps.201800361 · Cited by 61
Nanotherapeutics for Antimetastatic Treatment
Yang, F., Zhao, Z., Sun, B., Chen, Q., Sun, J., He, Z., & Luo, C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.05.001 · Cited by 74
Bioinspired DNA Nanointerface with Anisotropic Aptamers for Accurate Capture of Circulating Tumor Cells
Qin, W., Chen, L., Wang, Z., Li, Q., Fan, C., Wu, M., & Zhang, Y. (2020) · Advanced Science · doi:10.1002/advs.202000647 · Cited by 72
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
Silveira, A. B., Bidard, F., Tanguy, M., Girard, E., Trédan, O., Dubot, C., Jacot, W., Gonçalvès, A., Debled, M., Lévy, C., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00319-4 · Cited by 78
Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis
Msaouel, P., & Koutsilieris, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-336 · Cited by 74
A Multiscale TiO 2 Nanorod Array for Ultrasensitive Capture of Circulating Tumor Cells
Sun, N., Li, X., Wang, Z., Zhang, R., Wang, J., Wang, K., & Pei, R. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02178 · Cited by 74
Essentials of circulating tumor cells for clinical research and practice
Liberko, M., Kološtová, K., & Bobek, V. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.05.002 · Cited by 76
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Nagrath, S., Jack, R. M., Sahai, V., & Simeone, D. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.052 · Cited by 73
Single‐cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis
Ellsworth, D. L., Blackburn, H. L., Shriver, C. D., Rabizadeh, S., Soon‐Shiong, P., & Ellsworth, R. E. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0145-6 · Cited by 73
Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients
Drucker, A., Teh, E., Kostyleva, R., Rayson, D., Douglas, S. F., & Pinto, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237308 · Cited by 73
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
Botteri, E., Sandri, M. T., Bagnardi, V., Munzone, E., Zorzino, L., Rotmensz, N., Casadio, C., Cassatella, M. C., Espósito, A., Curigliano, G., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0668-7 · Cited by 73
A Cellular Compatible Chitosan Nanoparticle Surface for Isolation and In Situ Culture of Rare Number CTCs
Sun, N., Wang, J., Ji, L., Hong, S., Dong, J., Guo, Y., Zhang, K., & Pei, R. (2015) · Small · doi:10.1002/smll.201501718 · Cited by 73
High-throughput rare cell separation from blood samples using steric hindrance and inertial microfluidics
Shen, S., Ma, C., Zhao, L. Q., Wang, Y., Wang, J., Xu, J., Li, T., Pang, L., & Wang, J. (2014) · Lab on a Chip · doi:10.1039/c3lc51384j · Cited by 73
Multifunctional microfluidic chip for cancer diagnosis and treatment
Guo, Q., Zhang, L.-L., Liu, J., Li, Z., Li, J.-J., Zhou, W., Wang, H., Li, J., Liu, D., Yu, X., et al. (2020) · Nanotheranostics · doi:10.7150/ntno.49614 · Cited by 76
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Lee, J. S., Melisko, M., Magbanua, M. J. M., Kablanian, A., Scott, J. H., Rugo, H. S., & Park, J. W. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3610-1 · Cited by 72
Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients
Wong, S. C. C., Chan, C. M. L., Ma, B. B. Y., Hui, E. P., Ng, S. S. M., Lai, P. B. S., Cheung, M. T., Lo, E. S. F., Chan, A. K. C., Lam, M. Y. Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1515 · Cited by 72
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study
Paoletti, C., Miao, J., Dolce, E. M., Darga, E. P., Repollet, M., Doyle, G. V., Gralow, J. R., Hortobágyi, G. N., Smerage, J. B., Barlow, W. E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0208 · Cited by 72
Optical nanomaterial-based detection of biomarkers in liquid biopsy
Kim, Y. J., Rho, W., Park, S.-M., & Jun, B. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01531-y · Cited by 77
Probing Intracellular Biomarkers and Mediators of Cell Activation Using Nanosensors and Bioorthogonal Chemistry
Haun, J. B., Devaraj, N. K., Marinelli, B. S., Lee, H., & Weissleder, R. (2011) · ACS Nano · doi:10.1021/nn200333m · Cited by 72
Fluorescent analysis of bioactive molecules in single cells based on microfluidic chips
Fan, Y., Dong, D., Li, Q., Si, H., Pei, H., Lu, L., & Tang, B. (2018) · Lab on a Chip · doi:10.1039/c7lc01333g · Cited by 72
A microfluidic microwell device for immunomagnetic single-cell trapping
Huang, N., Hwong, Y.-J., & Lai, R. L. (2018) · Microfluidics and Nanofluidics · doi:10.1007/s10404-018-2040-x · Cited by 71
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Horimoto, Y., Tokuda, E., Murakami, F., Uomori, T., Himuro, T., Nakai, K., Orihata, G., Iijima, K., Togo, S., Shimizu, H., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1663-8 · Cited by 71
Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients
Mostert, B., Sieuwerts, A. M., Martens, J. W. M., & Sleijfer, S. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.11 · Cited by 73
Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
Liu, X., Cui, D.-N., Li, Y., Liu, Y., Liu, G., & Liu, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i30.4199 · Cited by 70
Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
Ginghină, O., Hudiță, A., Zamfir, M., Spânu, A., Mardare, M., Bondoc, I., Buburuzan, L., Georgescu, S. E., Costache, M., Negrei, C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856575 · Cited by 78
Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry
Lu, Y., Liang, H., Yu, T., Xie, J., Chen, S., Dong, H., Sinko, P. J., Lian, S., Xu, J., Wang, J., et al. (2015) · Cancer · doi:10.1002/cncr.29444 · Cited by 70
Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)
Pearl, M. L., Dong, H., Tulley, S., Zhao, Q., Golightly, M. G., Zucker, S., & Chen, W. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.03.002 · Cited by 70
Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
Lou, J., Ben, S., Yang, G., Liang, X., Wang, X., Ni, S., & Han, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080458 · Cited by 71
Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture
Wu, J.-C., Tseng, P.-Y., Tsai, W., Liao, M., Lu, S.-H., Frank, C. W., Chen, J., Wu, H., & Chang, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.096 · Cited by 70
Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery
Sandri, M. T., Zorzino, L., Cassatella, M. C., Bassi, F. D., Luini, A., Casadio, C., Botteri, E., Rotmensz, N., Adamoli, L., & Nolè, F. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0918-2 · Cited by 70
Acoustic impedance-based size-independent isolation of circulating tumour cells from blood using acoustophoresis
Subramani, K., Pradeep, P. N., Kanchana, P., & Sen, A. K. (2018) · Lab on a Chip · doi:10.1039/c8lc00921j · Cited by 70
The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy
Scioli, M. G., Storti, G., D’Amico, F., Gentile, P., Fabbri, G., Cervelli, V., & Orlandi, A. (2019) · Cancers · doi:10.3390/cancers11071021 · Cited by 71
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis
Rhun, É. L., Massin, F., Tu, Q., Bonneterre, J. M., Bittencourt, M. D. C., & Faure, G. C. (2012) · BMC Clinical Pathology · doi:10.1186/1472-6890-12-21 · Cited by 69
Micrometastasis in gastric cancer
Zhang, Z.-Y., & Ge, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.021 · Cited by 68
The RareCyte® platform for next‐generation analysis of circulating tumor cells
Kaldjian, E. P., Ramirez, A. B., Sun, Y., Campton, D. E., Werbin, J. L., Varshavskaya, P., Quarre, S., George, T., Madan, A., Blau, C. A., et al. (2018) · Cytometry Part A · doi:10.1002/cyto.a.23619 · Cited by 69
Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
McInnes, L. M., Jacobson, N., Redfern, A. D., DOWLING, A. J., Thompson, E. W., & Saunders, C. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00042 · Cited by 68
Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
Beije, N., Jager, A., & Sleijfer, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.12.008 · Cited by 71
A label-free DC impedance-based microcytometer for circulating rare cancer cell counting
Choi, H., Kim, K. B., Jeon, C. S., Hwang, I., Lee, S., Kim, H. K., Kim, H. C., & Chung, T. D. (2013) · Lab on a Chip · doi:10.1039/c2lc41376k · Cited by 69
Circulating biomarkers in hepatocellular carcinoma
Morris, K. L., Tugwood, J. D., Khoja, L., Lancashire, M., Sloane, R. A. S., Burt, D., Shenjere, P., Zhou, C., Hodgson, C., Ohtomo, T., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2508-7 · Cited by 68
An Automated High-Throughput Counting Method for Screening Circulating Tumor Cells in Peripheral Blood
Zhao, M., Schiro, P. G., Kuo, J. S., Koehler, K. M., Sabath, D. E., Popov, V., Feng, Q., & Chiu, D. T. (2013) · Analytical Chemistry · doi:10.1021/ac400193b · Cited by 68
Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system
Huang, Y.-Y., Hoshino, K., Chen, P., Wu, C.-H., Lane, N., Huebschman, M. L., Liu, H., Sokolov, K., Uhr, J. W., Frenkel, E. P., et al. (2012) · Biomedical Microdevices · doi:10.1007/s10544-012-9718-8 · Cited by 68
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
Imamura, T., Komatsu, S., Ichikawa, D., Kawaguchi, T., Miyamae, M., Okajima, W., Ohashi, T., Arita, T., Konishi, H., Shiozaki, A., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5627 · Cited by 73
PD-L1 expressing circulating tumour cells in head and neck cancers
Kulasinghe, A., Perry, C., Kenny, L., Warkiani, M. E., Nelson, C. C., & Punyadeera, C. (2017) · BMC Cancer · doi:10.1186/s12885-017-3316-3 · Cited by 68
Label-free ferrohydrodynamic cell separation of circulating tumor cells
Zhao, W., Cheng, R., Jenkins, B. D., Zhu, Τ., Okonkwo, N. E., Jones, C. E., Davis, M. B., Kavuri, S., Hao, Z., Schroeder, C., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00680b · Cited by 68
Filter‐based isolation, enrichment, and characterization of circulating tumor cells
Khetani, S., Mohammadi, M., & Sanati‐Nezhad, A. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26787 · Cited by 68
Circulating Tumor Cells and Sample Size: The More, the Better
Lalmahomed, Z. S., Kraan, J., Gratama, J. W., Mostert, B., Sleijfer, S., & Verhoef, C. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2764 · Cited by 68
Rational Design of Materials Interface for Efficient Capture of Circulating Tumor Cells
Li, Y., Chandran, B. K., Lim, C. T., & Chen, X. (2015) · Advanced Science · doi:10.1002/advs.201500118 · Cited by 68
Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
Chen, J.-Y., Tsai, W., Shao, H.-J., Wu, J.-C., Lai, J.-M., Lu, S.-H., Hung, T.-F., Yang, C.-T., Wu, L.-C., Chen, J.-S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149633 · Cited by 64
Aptamer-functionalized nano/micro-materials for clinical diagnosis: isolation, release and bioanalysis of circulating tumor cells
Zhao, Y., Xu, D., & Tan, W. (2017) · Integrative Biology · doi:10.1039/c6ib00239k · Cited by 67
New biomarkers for diagnosis and prognosis of localized prostate cancer
Chistiakov, D. A., Myasoedova, V. A., Grechko, A. V., Melnichenko, A. А., & Orekhov, A. N. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.012 · Cited by 67
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
Bergenfelz, C., Roxå, A., Mehmeti, M., Leandersson, K., & Larsson, A.-M. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02472-z · Cited by 67
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
Menyailo, M. E., Tretyakova, M. S., & Denisov, E. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051696 · Cited by 67
Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients
Mendelaar, P. A. J., Kraan, J., Van, M. N., Zeune, L. L., Terstappen, L. W. M. M., Hoop, E. O., Martens, J. W. M., & Sleijfer, S. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12802 · Cited by 67
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients
Wong, N. S., Kahn, H. J., Zhang, L., Oldfield, S., Yang, L., Marks, A., & Trudeau, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9181-4 · Cited by 67
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion
Wang, H., Stoecklein, N. H., Lin, P. P., & Gires, O. (2016) · Oncotarget · doi:10.18632/oncotarget.12242 · Cited by 69
Nanoscale metal–organic frameworks in detecting cancer biomarkers
Afreen, S., He, Z., Xiao, Y., & Zhu, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02579k · Cited by 67
An integrated microfluidic device for rapid and high-sensitivity analysis of circulating tumor cells
Jiang, J., Zhao, H., Shu, W., Tian, J., Huang, Y., Song, Y., Wang, R., Li, E., Slamon, D., Hou, D., et al. (2017) · Scientific Reports · doi:10.1038/srep42612 · Cited by 66
Circulating tumor cell profiling for precision oncology
Labib, M., & Kelley, S. O. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12901 · Cited by 68
Detection and characterization of circulating and disseminated prostate cancer cells
Todd, M. M. (2007) · Frontiers in bioscience · doi:10.2741/2290 · Cited by 66
Adhesion receptors as therapeutic targets for circulating tumor cells
Li, J., & King, M. R. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00079 · Cited by 66
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack
Bulfoni, M., Turetta, M., Ben, F. D., Loreto, C. D., Beltrami, A. P., & Cesselli, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101775 · Cited by 66
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Bitting, R. L., Schaeffer, D., Somarelli, J. A., García-Blanco, M. A., & Armstrong, A. J. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9483-z · Cited by 66
Recent advances in liquid biopsy technologies for cancer biomarker detection
Soda, N., Clack, K., & Shiddiky, M. J. A. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00010e · Cited by 66
Circulating tumor cells in the diagnosis and management of pancreatic cancer
Cen, P., Ni, X., Yang, J., Graham, D. Y., & Li, M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.007 · Cited by 65
Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids
Tsujiura, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3265 · Cited by 65
Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent
Qin, J., Alt, J. R., Hunsley, B. A., Williams, T. L., & Fernando, M. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-23 · Cited by 65
Circulating tumor cells before and during follow-up after breast cancer surgery
van Dalum, G., STAM, G. J. V. D., Tibbe, A. G. J., Franken, B., MASTBOOM, W. J. B., VERMES, I., de Groot, M. R., & Terstappen, L. W. M. M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2694 · Cited by 65
Aptamer-conjugated upconversion nanoprobes assisted by magnetic separation for effective isolation and sensitive detection of circulating tumor cells
Fang, S., Wang, C., Xiang, J., Cheng, L., Song, X., Xu, L., Peng, R., & Liu, Z. (2014) · Nano Research · doi:10.1007/s12274-014-0497-9 · Cited by 65
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
Mego, M., Gao, H., Cohen, E. N., Anfossi, S., Giordano, A., Tin, S., Fouad, T. M., Giorgi, U. D., Giuliano, M., Woodward, W. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10290 · Cited by 65
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1
Schehr, J. L., Schultz, Z. D., Warrick, J. W., Guckenberger, D. J., Pezzi, H. M., Sperger, J. M., Héninger, E., Saeed, A., Leal, T. A. B., Mattox, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159397 · Cited by 65
Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
Hou, J., Meng, F., Chan, L., Cho, W. C. S., & Wong, S. C. C. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00193 · Cited by 67
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
Kulasinghe, A., Wu, H., Punyadeera, C., & Warkiani, M. E. (2018) · Micromachines · doi:10.3390/mi9080397 · Cited by 67

Authors: Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
Affiliations: 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
The University of Texas Southwestern Medical Center (US)
ORCID: Miller, M. Craig
Terstappen, Leon W. M. M.
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-10-15
Volume: 10
Issue: 20
Pages: 6897-6904
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-04-0378
OpenAlex: W2116483002
Cited by: 2,542
References: 30
Citations by year: 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords: circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
MeSH terms: Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks